Preparation of neuraminidase-specific antiserum from the H9N2 subtype of avian influenza virus

Turkish Journal of Veterinary and Animal Sciences

Volumn 31, Issue 4, 2007, Pages 219-223

  Shirvan, Ali Nazari ^a   Moradi, Mehran ^b   Aminian, Mehdi ^a   Madani, Rasool ^a  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antiserum; Avian influenza; Neuraminidase

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 34948823863     PISSN: 13000128     EISSN: 13036181     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lamb, R.A., Krug, R.M.: Orthomyxoviridae. The viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley, P.M. Fields Virology. 2nd ed., Lippincott-Raven, Philadelphia. 1996; 1353-1395.
2. Air, G.M., Laver, W.G.: The neuraminidase of influenza virus. Proteins, 1989; 6: 341-56.
3. Saif, Y.M., Branes, H.J., Glisson, N.: Disease of Poultry, 11th ed., Iowa State Press, Ames, 2003; 35-153.
4. Tollis, M., Di Trani, L.: Recent developments in avian influenza research: epidemiology and immunoprophylaxis. Vet. J., 2002; 164: 202-215.
5. Bucher, D.J.: Purification of neuraminidase from influenza viruses by affinity chromatography. Biochim. Biophys. Acta., 1977; 482: 393-399.
6. Zamben, M.: Laboratory Diagnosis of Influenza. In: Nicholson, K.G., Webster, R.G., Hay, A.J. Textbook of Influenza. Blackwell Science, Oxford. 1998; 291-311.
7. Gallagher, M., Bucher, D.J., Dourmashkin, R., Davis, J.F., Rosenn, G., Kilbourne, E.D.: Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures. J. Clin. Microbiol., 1984; 20: 89-93.
8. Johansson, B.E., Matthews, J.T., Kilbourne, E.D.: Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine, 1998; 16: 1009-1015.
9. Abrashev, I.R., Genova, V.E., Sotirova, A.V., Ilieva, K.Z.: Purification and partial characterization of neuraminidase from the non-pathogenic Arthrobacter nicotianae. Enzyme Microb. Technol., 1998; 22: 142-146.
10. Fuhrer, J.P.: Rapid analysis of membrane glycopeptides by gel permeation high-performance liquid chromatography. J. Chromatogr B., 1990; 528: 65-77.
11. Hocart, M., Grajower, B., Donabedian, A., Pokorny, B., Whitaker, C., Kilbourne, E.D.: Preparation and characterization of a purified influenza virus neuraminidase vaccine. Vaccine, 1995; 13: 1793-1798.
12. Webster, R., Cox, N., Stohr, K.: WHO Manual on Animal Influenza Diagnosis and Surveillance. World Health Organization. 2002; 40-65.
13. O'Farrell, P.H.: High-resolution two-dimensional electrophoresis of proteins. J. Biol. Chem., 1975; 250: 4007-4021.
14. Morrissey, J.H.: Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem., 1981; 117: 307-310.
15. Bailey, G.S.: Raising of polyclonal antiserum to a protein. In: Walker, J.M. Basic Protein and Peptide Protocols. Humana Press, Totowa, NJ. 1994; 56-89.
16. Phelan, M.A., Mayner, R.E., Bucher, D.J., Ennis, F.A.: Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagent. J. Biol. Stand., 1980; 8: 233-242.
17. Johansson, B.E., Price, P.M., Kilbourne, E.D.: Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine, 1995; 13: 841-845.
18. 2+. J. Gen. Virol., 1971; 13: 481-483.
19. Ziegler, T., Hall, H., Sanchez-Fauquier, A., Gamble, W.C., Cox, N.J.: Type and subtype specific detection of influenza viruses in clinical specimens by rapid culture assay. J. Clin. Microbiol., 1995; 33: 318-321.